other material
confidence high
sentiment neutral
materiality 0.50
Madrigal shareholders approve 750K share increase to stock plan, extend to 2035
MADRIGAL PHARMACEUTICALS, INC.
- Stockholders approved amendment to 2015 Stock Plan, increasing share reserve by 750,000 shares.
- Plan extended through 2035; clawback policy and one-year minimum vesting requirement added.
- All three Class II director nominees (Sibold, Taub, Craves) elected with over 95% support.
- PricewaterhouseCoopers ratified as independent auditor for FY2024 with 99.4% of votes cast.